Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

CORPORATE SCORECARD-MJ PHARMA RECORDS Q3 LOSS OF Rs0.94 CRORE

Article Abstract:

MJ Pharma (MJP) has incurred net loss of Rs0.94 crore in the third quarter of 1998-99. It posted sales of Rs8.23 crore. MJP hived off its Halol unit as a separate company, Sibal Pharmaceuticals. Its shareholders will receive shares of Sibal in the ratio of 1:2 taking its equity to Rs3 crore. For the nine- month period it incurred net loss of Rs1.92 crore on sales of Rs25.85 crore. (gs)(psr)

Publisher: Bennett, Coleman & Co. Ltd.
Publication Name: Economic Times
Subject: Business, international
ISSN: 0013-0389
Year: 1999
MJ Pharma

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


PARKE-DAVIS NET AT Rs1.8 CR

Article Abstract:

Parke Davis India Ltd has increased its net profit by 54 percent to Rs1.8 crore for the third quarter ended December 1998 against Rs1.17 crore in the third quarter of 1997-98. Its sales increased to Rs47.57 crore from Rs46.67 crore. (khr)

Comment:

Parke Davis India Ltd has increased its net profit by 54 percent to Rs1.8 crore for the third quarter ended December 1998 against Rs1.17 crore in the third quarter of 1997-98.

Publisher: Bennett, Coleman & Co. Ltd.
Publication Name: Economic Times
Subject: Business, international
ISSN: 0013-0389
Year: 1999
Parke-Davis India Ltd.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Drugs, India
Similar abstracts:
  • Abstracts: A CHEMISTRY THAT WORKS: CIPLA CIPLA MAY SCRAP CHINA VENTURE
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.